E
Actuate Therapeutics, Inc. ACTU
$6.91 $0.213.13%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 2/3/2025Upgraded
Actuate Therapeutics, Inc. (ACTU) was upgraded to E from E- on 2/3/2025 due to a significant increase in the solvency index, total return index and volatility index. The quick ratio increased from 0.02 to 1.59.
E
Sell 11/5/2024None
Actuate Therapeutics, Inc. (ACTU) was downgraded to E- from U on 11/05/2024.
Weiss Ratings